For Australians living with MS, REBIF will no longer be available on the Pharmaceutical Benefits Scheme (PBS) from 1 December 2022.
Filter News Articles
02 November 2022
A decade in the making - $35 million dollars committed to research
We are excited and proud to announce that in the 2022/23 financial year, we are committing a further $5 million to neurological research!
21 October 2022
Carers: The Unsung Heroes
Who might be these invisible heroes? These people are commonly known as ‘carers’, but ‘common’ and ‘ordinary’ they are not.
18 October 2022
Evusheld and the PBS
On 14 October 2022, the Pharmaceutical Benefits Advisory Committee (PBAC) recommended that Evusheld not be listed on the Pharmaceutical Benefits Scheme (PBS). However, this may be revised in the future and access will remain through current schemes.
18 October 2022
An update about COVID-19
MSWA remains alert as we monitor the COVID-19 situation. This article provides a current updates and useful links for further information.
11 October 2022
Jasmin's Story
"We are so grateful that MSWA looks after us"
44-year-old Jasmin Franklin was born with a rare condition called Klippel-Feil Syndrome. Remarkably, the diagnosis took 40 years to be found.
Watch Jasmin's incredible story…
01 August 2022
Vumerity medication for relapsing-remitting MS, now approved under PBS
Vumerity® (diroximel fumarate) will be listed under the Pharmaceutical Benefit Scheme (PBS).
13 June 2022
We thank Ros Harman
Ros Harman has announced her resignation from the MSWA Board after 18 years of service and valued contribution.
09 June 2022
Researcher in Focus: Professor Bruno Meloni
MSWA is proud to be funding this important West Australian research, led by Professor Bruni Meloni, that will potentially provide the first effective treatment to minimise the damage that occurs in the early phases of stroke.
30 May 2022
Employment & Workplace Survey Results Released for World MS Day
The survey, where 1,748 Australians (of which 525 are living with MS) participated, revealed there is a disconnect between expectations and workplace realities for those with a health condition.
